Click here to learn about Academy events, publications and initiatives around COVID-19.

We are experiencing intermittent technical difficulties. At this time, you may not be able to log in, register for an event, or make a donation via the website. We appreciate your patience, and apologize for any inconvenience this may cause.

Support The World's Smartest Network
×

Help the New York Academy of Sciences bring late-breaking scientific information about the COVID-19 pandemic to global audiences. Please make a tax-deductible gift today.

DONATE
This site uses cookies.
Learn more.

×

This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

We encourage you to learn more about cookies on our site in our Privacy policy and Terms of Use.

Innovations in Maternal, Neonatal, and Early Infancy Vaccines

WEBINAR

Only

Innovations in Maternal, Neonatal, and Early Infancy Vaccines

Tuesday, June 23, 2020, 10:00 AM - 5:30 PM EDT

The New York Academy of Sciences, 7 World Trade Center, 250 Greenwich St Fl 40, New York

Presented By

 

Maternal, neonatal, and early infancy vaccines have the potential to significantly improve the health of mothers and children worldwide by reducing morbidity and mortality from diseases that are a risk to individuals early in life, and for which no alternative effective preventive strategies exist.  Although several existing vaccines have been shown to be safe and effective for use during pregnancy, there are no vaccines formally approved or licensed specifically for use in pregnant women.  Active research is taking place, with substantial progress continually made.  It is believed that licensure of new vaccines exclusively for use in pregnant woman to protect their newborns and infants will soon be an attainable goal.

This one-day scientific symposium spans basic science, clinical, epidemiological, translational, and policy research, and will provide a neutral forum to explore recent achievements and challenges in the development and licensure of novel maternal vaccines, as well as the utilization of currently licensed vaccines during pregnancy.  Through a series of keynote and plenary presentations, major themes on the program include: maternal-fetal immunology and physiology; lessons learned from vaccines currently used in pregnancy; new targets for maternal, neonatal, and early infancy immunization; and maternal immunization barriers to uptake.

Registration

Member
$30
Nonmember Academia, Faculty, etc.
$65
Nonmember Corporate, Other
$85
Nonmember Not for Profit
$65
Nonmember Student, Undergrad, Grad, Fellow
$45
Member Student, Post-Doc, Fellow
$15
Deadline:
0
days
left

Organizers

Annaliesa Anderson, PhD
Annaliesa Anderson, PhD

Pfizer

Gregory Glenn, MD
Gregory Glenn, MD

Novavax

Emmanuel Hanon
Emmanuel Hanon, PhD

GlaxoSmithKline

Wayne Koff
Wayne Koff, PhD

The Human Vaccines Project

Stanley Plotkin
Stanley Plotkin, MD

Vaxconsult LLC, University of Pennsylvania

Melanie Brickman Borchard, PhD, MSc
Melanie Brickman Borchard, PhD, MSc

New York Academy of Sciences

George Zavoico, PhD
George Zavoico, PhD

Senior Equity Analyst

Keynote Speaker

Shabir Madhi, MBBCh, FCPaeds(SA), PhD
Shabir Madhi, MBBCh, FCPaeds(SA), PhD

University of the Witwatersrand

Speakers

Barney Graham
Barney Graham, MD, PhD

National Institute of Allergy and Infectious Diseases (NIAID), NIH

Ruth Karron, MD
Ruth Karron, MD

Johns Hopkins Bloomberg School of Public Health

Kirsty Le Doare
Kirsty Le Doare, MD, PhD

St. George’s, University of London

Janet Englund
Janet Englund, MD

Seattle Children’s Hospital

Ofer Levy, MD, PhD
Ofer Levy, MD, PhD

Boston Children's Hospital; Harvard Medical School

Noel T. Mueller, PhD
Noel T. Mueller, PhD

Johns Hopkins University

Lenore Pereira, PhD
Lenore Pereira, PhD

University of California, San Francisco

Arnaud Marchant, MD, PhD
Arnaud Marchant, MD, PhD

Institute for Medical Immunology (IMI), Université Libre de Bruxelles

Ajoke Sobanjo-ter Meulen
Ajoke Sobanjo-ter Meulen, MD, MSc

Bill & Melinda Gates Foundation

Tuesday

June 23, 2020

10:00 AM

Welcome Remarks

Speaker

Sara Donnelly, PhD
New York Academy of Sciences
10:10 AM

Keynote Presentation

Speaker

Shabir Madhi, MBBCh, FCPaeds(SA), PhD
University of Witwatersrand

SESSION I: Maternal-Fetal Immunology and Physiology

Session Chairperson
Gregory Glenn, MD, Novavax
10:45 AM

Transplacental Antibody Transfer Following Maternal Immunization

Speaker

Arnaud Marchant, MD, PhD
Institute for Medical Immunology (IMI), Université Libre de Bruxelles
11:10 AM

Impact of Maternal Microbiota on Infant Microbiota and Development

Speaker

Noel T. Mueller, PhD
Johns Hopkins University
11:35 AM

Break

11:45 AM

Antibody Transfer from Mother to Infant: The Physiology of Breast Milk

Speaker

Kirsty Le Doare, MD, PhD
St. George’s, University of London
12:10 PM

The Structure of the Human Placenta Enables Humoral and Cellular Immune Defense

Speaker

Lenore Pereira, PhD
University of California, San Francisco

SESSION II: Lessons Learned from Current Maternal Vaccines

Session Chairperson
Stanley Plotkin, MD, Vaxconsult LLC; University of Pennsylvania
12:35 PM

Maternal Vaccines Licensed for Use in Adults: What Can Be Learned from Recent Experiences with Influenza, Pertussis, and Tetanus Vaccines

Speaker

Janet Englund, MD
Seattle Children’s Hospital
1:00 PM

Break

SESSION III: New Targets for Maternal, Neonatal, and Early Infancy Immunization

Session Chairperson
Annaliesa Anderson, PhD, Pfizer
1:30 PM

Cytomegalovirus (CMV): The Direct Effect of Preventing Maternal Infection and Transmission to the Fetus

Speaker

Stanley Plotkin, MD
Vaxconsult LLC, University of Pennsylvania
1:55 PM

Progress on Developing a Maternal Pre-fusion F Vaccine for the Prevention of Neonatal RSV Disease

Speaker

Kathrin Jansen, PhD
Pfizer
2:20 PM

Learnings from a Phase 3 RSV Clinical Trial

Speaker

Gregory Glenn, MD
Novavax
2:45 PM

New Modalities in Maternal Vaccines

Speaker

Emmanuel Hanon, PhD
GlaxoSmithKline
3:10 PM

Break

3:20 PM

Updates on Group B Streptococcus (GBS) Vaccine Development

Speaker

Ajoke Sobanjo-ter Meulen, MD, MSc
Bill & Melinda Gates Foundation
3:55 PM

Approaches to Infant Vaccination for RSV

Speaker

Barney Graham, MD, PhD
National Institute of Allergy and Infectious Diseases (NIAID), NIH
4:20 PM

Precision Vaccines to Shield the Young: Bringing Precision Medicine to Infant Vaccine Development

Speaker

Ofer Levy, MD, PhD
Boston Children's Hospital

SESSION IV: Maternal Immunization Barriers to Uptake

Session Chairperson
Emmanuel Hanon, PhD, GlaxoSmithKline
4:55 PM

Maternal Immunization Barriers to Uptake

Speaker

Ruth Karron, MD
Johns Hopkins Bloomberg School of Public Health
5:20 PM

Closing Remarks

Speaker

Sara Donnelly, PhD
New York Academy of Sciences
5:25 PM

Adjourn